Omics in Clinical Practice: Genomics, Pharmacogenomics, Proteomics, and Transcriptomics in Clinical Research

✍ Scribed by Yu Liu

Publisher: Apple Academic Press, CRC Press
Year: 2014
Tongue: English
Leaves: 456
Category: Library

No coin nor oath required. For personal study only.

✦ Synopsis

This book serves as an introduction to genomics, proteomics, and transcriptomics, putting these fields in relation to human disease and ailments. The various chapters consider the role of translation and personalized medicine, as well as pathogen detection, evolution, and infection, in relation to genomics, proteomics, and transcriptomics. The topic of companion diagnostics is also covered. The book is broken into Read more...

✦ Table of Contents

Content: Front Cover; About the Editor; Contents; Acknowledgment and How to Cite; List of Contributors; Introduction; Part I: Omics and Human Disease; Chapter 1: Comparative Mitochondrial Proteomics: Perspective in Human Diseases; Chapter 2: Studies of Complex Biological Systems with Applications to Molecular Medicine: The Need to Integrate Transcriptomic and Proteomic Approaches; Chapter 3: Next Generation Sequencing in Cancer Research and Clinical Application; Chapter 4: Scientific Challenges and Implementation Barriers to Translation of Pharmacogenomics in Clinical Practice Part II: Translational and Personalized MedicineChapter 5: Clinical Proteomics and Omics Clues Useful in Translational Medicine Research; Chapter 6: Genomes2Drugs: Identifies Target Proteins and Lead Drugs from Proteome Data; Part III: Molecular and Genetic Markers; Chapter 7: Pitfalls and Limitations in Translation from Biomarker Discovery to Clinical Utility in Predictive and Personalised Medicine; Chapter 8: How Bioinformatics Influences Health Informatics: Usage of Biomolecular Sequences, Expression Profiles, and Automated Microscopic Image Analyses for Clinical Needs and Public Health Chapter 9: Application of ''Omics'' to Prion Biomarker DiscoveryPart IV: Omics and Pathogens; Chapter 10: Insights from Genomics into Bacterial Pathogen Populations; Chapter 11: High Throughput Sequencing and Proteomics to Identify Immunogenic Proteins of a New Pathogen: The Dirty Genome Approach; Chapter 12: Coronavirus Genomics and Bioinformatics Analysis; Part V: Companion Diagnostics; Chapter 13: Applications of Next-Generation Sequencing Technologies to Diagnostic Virology
Abstract: This book serves as an introduction to genomics, proteomics, and transcriptomics, putting these fields in relation to human disease and ailments. The various chapters consider the role of translation and personalized medicine, as well as pathogen detection, evolution, and infection, in relation to genomics, proteomics, and transcriptomics. The topic of companion diagnostics is also covered. The book is broken into five sections. Part I examines the connection between omics and human disease. Part II looks at the applications for the fields of translational and personalized med

✦ Subjects

Медицинские дисциплины;

📜 SIMILAR VOLUMES

Genomics and Pharmacogenomics in Antican

📁 Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response

✍ Federico Innocenti 📂 Library 📅 2008 🏛 Humana Press 🌐 English

<P>The availability of new molecular approaches to the selection of drug therapy is an emerging need, as the traditional approach based on the evaluation of patient and tumor characteristics is clearly far from optimal. Many, and in most cases the majority of treated patients do not have significant

Genomics and Pharmacogenomics in Antican

📁 Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response

✍ Natalie Stickle MSc, Neil Winegarden MSc (auth.), Federico Innocenti (eds.) 📂 Library 📅 2009 🏛 Humana Press 🌐 English

<p><P>The availability of new molecular approaches to the selection of drug therapy is an emerging need, as the traditional approach based on the evaluation of patient and tumor characteristics is clearly far from optimal. Many, and in most cases the majority of treated patients do not have signific

Pharmacogenomic Testing in Current Clini

📁 Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory

✍ Kiang-Teck J. Yeo, Nikolina Babic, Alan H. B. Wu (auth.), Alan H. B. Wu, Kiang-T 📂 Library 📅 2011 🏛 Humana Press 🌐 English

<p>While the basic principles of personalized medicine and pharmacogenomics has been covered by numerous texts, there are none to date that focuses on the specific tests themselves that are in current clinical practice and those that are being proposed for implementation in the near future. Pharmaco

Pharmacogenomic Testing in Current Clini

📁 Pharmacogenomic Testing in Current Clinical Practice: Implementation in the Clinical Laboratory (Molecular and Translational Medicine)

✍ Alan H.B. Wu, Kiang-Teck J. Yeo 📂 Library 📅 2011 🏛 Humana Press 🌐 English

While the basic principles of personalized medicine and pharmacogenomics has been covered by numerous texts, there are none to date that focuses on the specific tests themselves that are in current clinical practice and those that are being proposed for implementation in the near future. Pharmacogen

Functional Genomics and Proteomics in th

📁 Functional Genomics and Proteomics in the Clinical Neurosciences

✍ S.E. Hemby and S. Bahn (Eds.) 📂 Library 📅 2006 🏛 Elsevier B. V 🌐 English

The purpose of this work is to familiarize neuroscientists with the available tools for proteome research and their relative abilities and limitations. To know the identities of the thousands of different proteins in a cell, and the modifications to these proteins, along with how the amounts of both

Pharmacogenomics in Clinical Therapeutic

📁 Pharmacogenomics in Clinical Therapeutics

📂 Library 📅 2012 🏛 Wiley-Blackwell 🌐 English

Pharmacogenomics is the basis of personalized medicine which will be the medicine of the future. Through both reducing the numbers of adverse drug reactions and improving the use of existing drugs in targeted populations, pharmacogenomics represents a real advance on traditional therapeutic drug mon